4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with Asthma, Bronchial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoscato, AA; Anthonymuthu, TS; Bahar, I; Bayır, H; Dar, HH; Emlet, DR; Holman, TR; Kagan, VE; Kapralov, AA; Kellum, JA; Kenny, EM; Mao, G; Mikulska-Ruminska, K; Minami, Y; Qu, F; Rosenbaum, JC; Shrivastava, IH; Sparvero, LJ; St Croix, CM; Tyurin, VA; Tyurina, YY; VanDemark, AP; Watkins, SC; Wen, X; Wenzel, SE; Yang, Q; Zhao, J | 1 |
1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and Asthma, Bronchial
| Article | Year |
|---|---|
PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals.
Topics: Acute Kidney Injury; Animals; Apoptosis; Asthma; Brain Injuries, Traumatic; Cell Death; Cell Line; Humans; Isoenzymes; Lipoxygenase; Mice; Models, Molecular; Oxazolidinones; Oxidation-Reduction; Phosphatidylethanolamine Binding Protein | 2017 |